Early research (Phase 1)Study completedNCT07035990
What this trial is testing
Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
Who this might be right for
Cystic Fibrosis (CF)
Sionna Therapeutics Inc. 120